{"id":5854,"date":"2026-02-12T13:32:15","date_gmt":"2026-02-12T12:32:15","guid":{"rendered":"https:\/\/wellnessforum.pro\/?p=5854"},"modified":"2026-02-12T13:32:17","modified_gmt":"2026-02-12T12:32:17","slug":"er-100-the-first-clinical-trial-of-partial-epigenetic-reprogramming-in-humans","status":"publish","type":"post","link":"https:\/\/wellnessforum.pro\/en\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\/","title":{"rendered":"ER-100: the first clinical trial of partial epigenetic reprogramming in humans"},"content":{"rendered":"<p>For decades we assumed that ageing was a linear, cumulative and inevitable process. Today, biology is challenging that paradigm. Epigenetics - the system of chemical marks that regulates which genes are turned on or silenced - has become one of the most promising territories in longevity medicine.<\/p>\n\n\n\n<p>What once seemed like science fiction is now entering the clinical phase: <strong>partial epigenetic reprogramming already being tested in humans<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">The origin of the concept: resetting without erasing identity<\/h2>\n\n\n\n<p>Cell reprogramming became world-renowned with the discovery of Yamanaka's factors (OCT4, SOX2, KLF4 and c-MYC), which are capable of converting adult cells into induced pluripotent stem cells (iPSCs). This process erases cell identity and resets the biological state to an embryonic stage.<\/p>\n\n\n\n<p>The problem: complete reprogramming implies loss of specialised function and risk of tumourigenicity.<\/p>\n\n\n\n<p>The solution that has emerged in the last decade is the <strong>partial reprogramming<\/strong>Temporary activation of some factors (usually OCT4, SOX2 and KLF4, without c-MYC) to rejuvenate the epigenome without de-differentiating the cell.<\/p>\n\n\n\n<p>In animal models, this strategy has:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Vision restored in mice with optic nerve damage<\/li>\n\n\n\n<li>Improved tissue function in ageing tissues<\/li>\n\n\n\n<li>Reduced epigenetic age measured by molecular clocks<\/li>\n\n\n\n<li>Increased health parameters in accelerated ageing models<\/li>\n<\/ul>\n\n\n\n<p>The key finding is that <strong>youth information appears to be conserved in the epigenome<\/strong>, and can be reactivated.<\/p>\n\n\n\n<p>In 2026, the FDA authorised the start of the first human clinical trial based on this technology. The treatment is called <strong>ER-100<\/strong>, developed by <strong><a href=\"https:\/\/www.lifebiosciences.com\/life-biosciences-announces-fda-clearance-of-ind-application-for-er-100-in-optic-neuropathies\/\">Life Biosciences<\/a><\/strong>.<\/p>\n\n\n\n<p>This phase 1 study evaluates safety and preliminary efficacy signals in patients with<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Open-angle glaucoma<\/li>\n\n\n\n<li>Non-arteritic anterior ischaemic optic neuropathy (NAION)<\/li>\n<\/ul>\n\n\n\n<p>Both pathologies involve degeneration of retinal ganglion cells and progressive damage to the optic nerve.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"300\" src=\"https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/ER-100-Life-Bioscience-1024x300.png\" alt=\"\" class=\"wp-image-5856\" srcset=\"https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/ER-100-Life-Bioscience-1024x300.png 1024w, https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/ER-100-Life-Bioscience-300x88.png 300w, https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/ER-100-Life-Bioscience-768x225.png 768w, https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/ER-100-Life-Bioscience-1536x450.png 1536w, https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/ER-100-Life-Bioscience-18x5.png 18w, https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/ER-100-Life-Bioscience.png 1542w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">What exactly does ER-100 consist of?<\/h2>\n\n\n\n<p>ER-100 is a <strong>locally administered intraocular gene therapy<\/strong> which uses an adeno-associated viral vector (AAV) to introduce a controlled set of reprogramming factors into cells:<\/p>\n\n\n\n<p><strong>OCT4, SOX2 and KLF4 (OSK)<\/strong><\/p>\n\n\n\n<p>These factors do not modify the DNA itself, but reorganise epigenetic marks (DNA methylation, chromatin remodelling, histone modifications), restoring more youthful gene expression patterns.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Critical differential element: temporal control<\/h3>\n\n\n\n<p>One of the most sophisticated aspects of the design is that the expression of the factors is under a <strong>inducible system<\/strong>, activatable by doxycycline. This allows:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Activate reprogramming for a limited period of time<\/li>\n\n\n\n<li>Stop if adverse effects occur<\/li>\n\n\n\n<li>Minimising the risk of dedifferentiation<\/li>\n<\/ul>\n\n\n\n<p>This temporal control is one of the main differences from previous attempts at more aggressive reprogramming.<\/p>\n\n\n\n<h1 class=\"wp-block-heading\">Why start with the eye?<\/h1>\n\n\n\n<p>The choice is not accidental.<\/p>\n\n\n\n<p>The ocular environment offers strategic advantages:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>It is a relatively isolated compartment (less systemic exposure).<\/li>\n\n\n\n<li>Enables accurate local administration.<\/li>\n\n\n\n<li>Visual function is measurable with objective biomarkers.<\/li>\n\n\n\n<li>There is strong preclinical data in animal models.<\/li>\n<\/ol>\n\n\n\n<p>In non-human primates, OSK expression restored juvenile epigenetic patterns and improved neuronal function after optic damage.<\/p>\n\n\n\n<p>The eye functions here as <strong>controlled test model to validate biosafety<\/strong> before considering systemic applications.<\/p>\n\n\n\n<h1 class=\"wp-block-heading\">How does ER-100 differ from other longevity approaches?<\/h1>\n\n\n\n<p>Most current longevity interventions address the consequences of ageing:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Senolytics \u2192 eliminate senescent cells<\/li>\n\n\n\n<li>Metformin or rapamycin \u2192 modulate metabolic pathways<\/li>\n\n\n\n<li>NAD+ boosters \u2192 support mitochondrial metabolism<\/li>\n\n\n\n<li>Hormone therapies \u2192 restore declining levels<\/li>\n<\/ul>\n\n\n\n<p>ER-100 is conceptually different:<br><strong>does not modulate the damage, it attempts to restore the original cellular programming.<\/strong><\/p>\n\n\n\n<p>It is an upstream intervention on the epigenetic architecture that regulates multiple biological processes simultaneously.<\/p>\n\n\n\n<p>This places it in a potentially transformative category.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"666\" src=\"https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/David_Sinclair-1-1024x666.jpg\" alt=\"\" class=\"wp-image-5857\" srcset=\"https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/David_Sinclair-1-1024x666.jpg 1024w, https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/David_Sinclair-1-300x195.jpg 300w, https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/David_Sinclair-1-768x499.jpg 768w, https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/David_Sinclair-1-1536x999.jpg 1536w, https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/David_Sinclair-1-2048x1331.jpg 2048w, https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/David_Sinclair-1-18x12.jpg 18w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h1 class=\"wp-block-heading\">Clinical potential if results are positive<\/h1>\n\n\n\n<p>If safety and functional efficacy are demonstrated, the implications would be profound:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Neurodegeneration<\/h3>\n\n\n\n<p>It could open a pathway for diseases such as Parkinson's or Alzheimer's, where epigenetic dysfunction contributes to neuronal loss.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">2. Tissue regeneration<\/h3>\n\n\n\n<p>Restore function in tissues with low regenerative capacity (heart, retina, nervous system).<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Preventive medicine of ageing<\/h3>\n\n\n\n<p>Rejuvenate epigenetic profiles before overt pathology appears.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">4. Biomarkers of biological age<\/h3>\n\n\n\n<p>Validate epigenetic clocks as clinical tools to measure actual reversal of ageing.<\/p>\n\n\n\n<p>We are talking about intervening on the common denominator of multiple age-related diseases.<\/p>\n\n\n\n<h1 class=\"wp-block-heading\">Risks and scientific prudence<\/h1>\n\n\n\n<p>Enthusiasm must be balanced with caution.<\/p>\n\n\n\n<p>Potential risks include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Oncogenic activation<\/li>\n\n\n\n<li>Epigenetic instability<\/li>\n\n\n\n<li>Immune response to the viral vector<\/li>\n\n\n\n<li>Long-term unintended effects<\/li>\n<\/ul>\n\n\n\n<p>Phase 1 is focused on safety. It does not seek to demonstrate systemic rejuvenation, but to establish that the procedure is feasible in humans.<\/p>\n\n\n\n<h1 class=\"wp-block-heading\">A paradigm shift in health and wellbeing<\/h1>\n\n\n\n<p>From the perspective of well-being and longevity, this trial marks a turning point. For the first time, the hypothesis that ageing is biologically reversible is being evaluated under formal regulatory oversight.<\/p>\n\n\n\n<p>This is not a supplement, nor is it a molecular cosmetic intervention. We are looking at the possibility that the epigenome - that dynamic system that organises our biological identity - can be reprogrammed in a controlled way.<\/p>\n\n\n\n<p>If safety is confirmed and positive functional signals appear, the impact could redefine 21st century medicine: from treating individual diseases to restoring the functional youthfulness of tissues.<\/p>\n\n\n\n<p>The biological clock no longer seems so immutable.<\/p>","protected":false},"excerpt":{"rendered":"<p>Durante d\u00e9cadas asumimos que el envejecimiento era un proceso lineal, acumulativo e inevitable. Hoy, la biolog\u00eda est\u00e1 cuestionando ese paradigma. La epigen\u00e9tica \u2014el sistema de marcas qu\u00edmicas que regula qu\u00e9 genes se activan o silencian\u2014 se ha convertido en uno de los territorios m\u00e1s prometedores de la medicina de longevidad. Lo que antes parec\u00eda ciencia [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":5855,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[162,80,310],"tags":[417],"class_list":["post-5854","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualidad","category-gurus","category-longevity","tag-epigenetica"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ER-100: el primer ensayo cl\u00ednico de reprogramaci\u00f3n epigen\u00e9tica parcial en humanos<\/title>\n<meta name=\"description\" content=\"la FDA autoriz\u00f3 el inicio del primer ensayo cl\u00ednico en humanos basado en esta tecnolog\u00eda. El tratamiento se denomina ER-100\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/wellnessforum.pro\/en\/er-100-the-first-clinical-trial-of-partial-epigenetic-reprogramming-in-humans\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ER-100: el primer ensayo cl\u00ednico de reprogramaci\u00f3n epigen\u00e9tica parcial en humanos\" \/>\n<meta property=\"og:description\" content=\"la FDA autoriz\u00f3 el inicio del primer ensayo cl\u00ednico en humanos basado en esta tecnolog\u00eda. El tratamiento se denomina ER-100\" \/>\n<meta property=\"og:url\" content=\"https:\/\/wellnessforum.pro\/en\/er-100-the-first-clinical-trial-of-partial-epigenetic-reprogramming-in-humans\/\" \/>\n<meta property=\"og:site_name\" content=\"Wellness Forum\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-12T12:32:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-12T12:32:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/David-Sinclair-Life-Biosciences_0adc7389-f29c-482e-8904-90df564c238d.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1241\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nadia Tresoro\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nadia Tresoro\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/wellnessforum.pro\\\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/wellnessforum.pro\\\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\\\/\"},\"author\":{\"name\":\"Nadia Tresoro\",\"@id\":\"https:\\\/\\\/wellnessforum.pro\\\/#\\\/schema\\\/person\\\/d9ff1cceff0b8f1d118cb255379e1e8e\"},\"headline\":\"ER-100: el primer ensayo cl\u00ednico de reprogramaci\u00f3n epigen\u00e9tica parcial en humanos\",\"datePublished\":\"2026-02-12T12:32:15+00:00\",\"dateModified\":\"2026-02-12T12:32:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/wellnessforum.pro\\\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\\\/\"},\"wordCount\":979,\"publisher\":{\"@id\":\"https:\\\/\\\/wellnessforum.pro\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/wellnessforum.pro\\\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/wellnessforum.pro\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/David-Sinclair-Life-Biosciences_0adc7389-f29c-482e-8904-90df564c238d.jpg\",\"keywords\":[\"epigen\u00e9tica\"],\"articleSection\":[\"Actualidad\",\"Gurus\",\"Longevity\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/wellnessforum.pro\\\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\\\/\",\"url\":\"https:\\\/\\\/wellnessforum.pro\\\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\\\/\",\"name\":\"ER-100: el primer ensayo cl\u00ednico de reprogramaci\u00f3n epigen\u00e9tica parcial en humanos\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/wellnessforum.pro\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/wellnessforum.pro\\\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/wellnessforum.pro\\\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/wellnessforum.pro\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/David-Sinclair-Life-Biosciences_0adc7389-f29c-482e-8904-90df564c238d.jpg\",\"datePublished\":\"2026-02-12T12:32:15+00:00\",\"dateModified\":\"2026-02-12T12:32:17+00:00\",\"description\":\"la FDA autoriz\u00f3 el inicio del primer ensayo cl\u00ednico en humanos basado en esta tecnolog\u00eda. El tratamiento se denomina ER-100\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/wellnessforum.pro\\\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/wellnessforum.pro\\\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/wellnessforum.pro\\\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\\\/#primaryimage\",\"url\":\"https:\\\/\\\/wellnessforum.pro\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/David-Sinclair-Life-Biosciences_0adc7389-f29c-482e-8904-90df564c238d.jpg\",\"contentUrl\":\"https:\\\/\\\/wellnessforum.pro\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/David-Sinclair-Life-Biosciences_0adc7389-f29c-482e-8904-90df564c238d.jpg\",\"width\":1241,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/wellnessforum.pro\\\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/wellnessforum.pro\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Actualidad\",\"item\":\"https:\\\/\\\/wellnessforum.pro\\\/actualidad\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"ER-100: el primer ensayo cl\u00ednico de reprogramaci\u00f3n epigen\u00e9tica parcial en humanos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/wellnessforum.pro\\\/#website\",\"url\":\"https:\\\/\\\/wellnessforum.pro\\\/\",\"name\":\"Wellness Forum\",\"description\":\"\u00bfQuieres una vida m\u00e1s saludable y pr\u00f3spera? Visita Wellness Forum y encuentra las mejores gu\u00edas y consejos en salud, bienestar y riqueza. \u00a1Empieza tu transformaci\u00f3n!\",\"publisher\":{\"@id\":\"https:\\\/\\\/wellnessforum.pro\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/wellnessforum.pro\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/wellnessforum.pro\\\/#organization\",\"name\":\"Wellness Forum\",\"url\":\"https:\\\/\\\/wellnessforum.pro\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/wellnessforum.pro\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/wellnessforum.pro\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/160LOGO-WF.png\",\"contentUrl\":\"https:\\\/\\\/wellnessforum.pro\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/160LOGO-WF.png\",\"width\":235,\"height\":160,\"caption\":\"Wellness Forum\"},\"image\":{\"@id\":\"https:\\\/\\\/wellnessforum.pro\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/wellnessforum.pro\\\/#\\\/schema\\\/person\\\/d9ff1cceff0b8f1d118cb255379e1e8e\",\"name\":\"Nadia Tresoro\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1f61d2512baeae917923e36d03cd5d197e8a08ee8f8b2a41dcc1f094e26312c4?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1f61d2512baeae917923e36d03cd5d197e8a08ee8f8b2a41dcc1f094e26312c4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1f61d2512baeae917923e36d03cd5d197e8a08ee8f8b2a41dcc1f094e26312c4?s=96&d=mm&r=g\",\"caption\":\"Nadia Tresoro\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ER-100: the first clinical trial of partial epigenetic reprogramming in humans","description":"the FDA authorised the start of the first human clinical trial based on this technology. The treatment is called ER-100","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/wellnessforum.pro\/en\/er-100-the-first-clinical-trial-of-partial-epigenetic-reprogramming-in-humans\/","og_locale":"en_GB","og_type":"article","og_title":"ER-100: el primer ensayo cl\u00ednico de reprogramaci\u00f3n epigen\u00e9tica parcial en humanos","og_description":"la FDA autoriz\u00f3 el inicio del primer ensayo cl\u00ednico en humanos basado en esta tecnolog\u00eda. El tratamiento se denomina ER-100","og_url":"https:\/\/wellnessforum.pro\/en\/er-100-the-first-clinical-trial-of-partial-epigenetic-reprogramming-in-humans\/","og_site_name":"Wellness Forum","article_published_time":"2026-02-12T12:32:15+00:00","article_modified_time":"2026-02-12T12:32:17+00:00","og_image":[{"width":1241,"height":800,"url":"https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/David-Sinclair-Life-Biosciences_0adc7389-f29c-482e-8904-90df564c238d.jpg","type":"image\/jpeg"}],"author":"Nadia Tresoro","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Nadia Tresoro","Estimated reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/wellnessforum.pro\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\/#article","isPartOf":{"@id":"https:\/\/wellnessforum.pro\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\/"},"author":{"name":"Nadia Tresoro","@id":"https:\/\/wellnessforum.pro\/#\/schema\/person\/d9ff1cceff0b8f1d118cb255379e1e8e"},"headline":"ER-100: el primer ensayo cl\u00ednico de reprogramaci\u00f3n epigen\u00e9tica parcial en humanos","datePublished":"2026-02-12T12:32:15+00:00","dateModified":"2026-02-12T12:32:17+00:00","mainEntityOfPage":{"@id":"https:\/\/wellnessforum.pro\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\/"},"wordCount":979,"publisher":{"@id":"https:\/\/wellnessforum.pro\/#organization"},"image":{"@id":"https:\/\/wellnessforum.pro\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\/#primaryimage"},"thumbnailUrl":"https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/David-Sinclair-Life-Biosciences_0adc7389-f29c-482e-8904-90df564c238d.jpg","keywords":["epigen\u00e9tica"],"articleSection":["Actualidad","Gurus","Longevity"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/wellnessforum.pro\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\/","url":"https:\/\/wellnessforum.pro\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\/","name":"ER-100: the first clinical trial of partial epigenetic reprogramming in humans","isPartOf":{"@id":"https:\/\/wellnessforum.pro\/#website"},"primaryImageOfPage":{"@id":"https:\/\/wellnessforum.pro\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\/#primaryimage"},"image":{"@id":"https:\/\/wellnessforum.pro\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\/#primaryimage"},"thumbnailUrl":"https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/David-Sinclair-Life-Biosciences_0adc7389-f29c-482e-8904-90df564c238d.jpg","datePublished":"2026-02-12T12:32:15+00:00","dateModified":"2026-02-12T12:32:17+00:00","description":"the FDA authorised the start of the first human clinical trial based on this technology. The treatment is called ER-100","breadcrumb":{"@id":"https:\/\/wellnessforum.pro\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/wellnessforum.pro\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/wellnessforum.pro\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\/#primaryimage","url":"https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/David-Sinclair-Life-Biosciences_0adc7389-f29c-482e-8904-90df564c238d.jpg","contentUrl":"https:\/\/wellnessforum.pro\/wp-content\/uploads\/2026\/02\/David-Sinclair-Life-Biosciences_0adc7389-f29c-482e-8904-90df564c238d.jpg","width":1241,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/wellnessforum.pro\/er-100-el-primer-ensayo-clinico-de-reprogramacion-epigenetica-parcial-en-humanos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/wellnessforum.pro\/"},{"@type":"ListItem","position":2,"name":"Actualidad","item":"https:\/\/wellnessforum.pro\/actualidad\/"},{"@type":"ListItem","position":3,"name":"ER-100: el primer ensayo cl\u00ednico de reprogramaci\u00f3n epigen\u00e9tica parcial en humanos"}]},{"@type":"WebSite","@id":"https:\/\/wellnessforum.pro\/#website","url":"https:\/\/wellnessforum.pro\/","name":"Wellness Forum","description":"Do you want a healthier and more prosperous life? Visit the Wellness Forum and find the best guides and advice on health, wellness and wealth - start your transformation!","publisher":{"@id":"https:\/\/wellnessforum.pro\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/wellnessforum.pro\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/wellnessforum.pro\/#organization","name":"Wellness Forum","url":"https:\/\/wellnessforum.pro\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/wellnessforum.pro\/#\/schema\/logo\/image\/","url":"https:\/\/wellnessforum.pro\/wp-content\/uploads\/2023\/09\/160LOGO-WF.png","contentUrl":"https:\/\/wellnessforum.pro\/wp-content\/uploads\/2023\/09\/160LOGO-WF.png","width":235,"height":160,"caption":"Wellness Forum"},"image":{"@id":"https:\/\/wellnessforum.pro\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/wellnessforum.pro\/#\/schema\/person\/d9ff1cceff0b8f1d118cb255379e1e8e","name":"Nadia Tresoro","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/1f61d2512baeae917923e36d03cd5d197e8a08ee8f8b2a41dcc1f094e26312c4?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1f61d2512baeae917923e36d03cd5d197e8a08ee8f8b2a41dcc1f094e26312c4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1f61d2512baeae917923e36d03cd5d197e8a08ee8f8b2a41dcc1f094e26312c4?s=96&d=mm&r=g","caption":"Nadia Tresoro"}}]}},"_links":{"self":[{"href":"https:\/\/wellnessforum.pro\/en\/wp-json\/wp\/v2\/posts\/5854","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wellnessforum.pro\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wellnessforum.pro\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wellnessforum.pro\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/wellnessforum.pro\/en\/wp-json\/wp\/v2\/comments?post=5854"}],"version-history":[{"count":1,"href":"https:\/\/wellnessforum.pro\/en\/wp-json\/wp\/v2\/posts\/5854\/revisions"}],"predecessor-version":[{"id":5858,"href":"https:\/\/wellnessforum.pro\/en\/wp-json\/wp\/v2\/posts\/5854\/revisions\/5858"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wellnessforum.pro\/en\/wp-json\/wp\/v2\/media\/5855"}],"wp:attachment":[{"href":"https:\/\/wellnessforum.pro\/en\/wp-json\/wp\/v2\/media?parent=5854"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wellnessforum.pro\/en\/wp-json\/wp\/v2\/categories?post=5854"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wellnessforum.pro\/en\/wp-json\/wp\/v2\/tags?post=5854"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}